Myriad Genetics Inc (MYGN)

EBITDA Margin

-13.63%

Quarterly · Period ending:

MYGN logo

MYGN EBITDA Margin

Latest reported-13.63%
MYGN Quarterly EBITDA Margin (100.00% → -13.63%)
High-resolution chart · PNG

MYGN ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-22.7452%
-19.8727%
-19.2874%
-21.6479%
-28.3978%
-23.088%
-19.2771%
-26.087%
-33.3333%
-27.4406%
-45.614%
-46.4286%
-44.6154%
-47.3684%
-45.098%
-32.2034%
2.6667%
-122.2222%
-132.1429%
-145.4545%
-125%
-121.0526%
-94.1176%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.